INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 429m ago
House PTR29m ago
SEC 13F28m ago
Robinhood Chain28m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 60S60 trades$277K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,584 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
MM
Moore MichaelPresident
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
34.2K sh
Jan 21, 2026Jan 23, 2026
Page 1410 of 1790
← PrevNext →
traded Jan 21, 2026
+2d
SEC Form 4

Evidence

21
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
12.4K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
HK
Huffman Patrick KipSVP, Chief Accounting Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
950 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

21
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
49.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
CJ
Cambre JeromeVice President of Sales
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
2,930 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
EA
Eidson Charles AndrewDirector, Chief Executive Officer
AMRAlpha Metallurgical Resources, Inc.
Grant or award
A—
8,197 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,542 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,542 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
MJ
Mcdearman JohnDirector, President & CEO
NONENONEWILSON BANK HOLDING CO
Option exercise
M—
1,500 sh
Jan 23, 2026Jan 23, 2026
traded Jan 23, 2026
+0dSEC Form 4

Evidence

21
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
3,334 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
28.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
HV
Hintelmann Robert Victor Jr.Chief Credit Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
2,850 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

20
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$51K
1,977 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

20
TJ
Thompson Amanda JChief People Officer
GAPGAP INC
Tax withholding
F$201K
7,396 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

19
TD
Townsell DonnaDirector, Director of Investor Relations
HOMBHOME BANCSHARES INC
Option exercise
M$425K
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

19
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Open-market sale · 10b5-1 plan
SELL$97K
2,119 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

19
OD
Owens DarrellSee remarks
SYFSynchrony Financial
Tax withholding
F$379K
4,909 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

19
TD
Townsell DonnaDirector, Director of Investor Relations
HOMBHOME BANCSHARES INC
Tax withholding
F$425K
14.4K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$67K
12.7K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
FR
Freeman Danyl RChief Human Resources Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
704 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M—
522 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
TJ
Thompson Amanda JChief People Officer
GAPGAP INC
Disposition to issuer
D—
20.2K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
543 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
Marshall William SpencerDirector, Co-Founder and CEO
PLPlanet Labs PBC
Option exercise
M—
123.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
ZR
Zirk Angela REVP, Chief Experience Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
488 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
HJ
Hager JosephChief Operating Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
1,980 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
SP
Schmidt Jennifer PalmerEVP, Chief Risk Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
1,074 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
10.4K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
SH
Schingler Robert HDirector, Co-Founder Chief Strategy Off.
PLPlanet Labs PBC
Option exercise
M—
36.4K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
WE
Whitehead Jason E.President & COO
AMRAlpha Metallurgical Resources, Inc.
Grant or award
A—
4,128 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
AC
Archibold Raimundo C. JrDirector
CHMGCHEMUNG FINANCIAL CORP
Grant or award
A$33K
574 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
JM
Joshi ManherChief Development Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
4,100 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
MM
Moore MichaelPresident
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
34.2K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
SH
Schingler Robert HDirector, Co-Founder Chief Strategy Off.
PLPlanet Labs PBC
Option exercise
M—
292.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
RB
Rowan Shannon BarrowEVP, Wealth Services
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
834 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

17
Marshall William SpencerDirector, Co-Founder and CEO
PLPlanet Labs PBC
Option exercise
M—
292.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
VS
Valentine Andre SChief Financial Officer
CNXCConcentrix Corp
Grant or award
A—
25.7K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Open-market sale
SELL$19K
1,600 sh
Jan 23, 2026Jan 23, 2026
traded Jan 23, 2026
+0dSEC Form 4

Evidence

17
CA
Caldwell Christopher ADirector, President and CEO
CNXCConcentrix Corp
Grant or award
A—
93.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

17
NK
Norrett KevinChief Business Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
3,500 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence